SKA1 and neoplasm: Spindle and kinetochore-associated complex subunit 1 (SKA1) can promote oxaliplatin resistance in breast cancer cells by activating the Notch and Wnt pathways [15]; inhibition of spindle and kinetochore-associated complex subunit 2/3 (SKA2/3) attenuates proliferation and migration of tumor cells [16].